PharmaShots | Incisive News in 3 Shots

Subscribe Now

Full approval

Astellas and Seagen's Padcev (enfortumab vedotin-ejfv) Receive the US FDA's Full Approval and Expands Indication for Patients with Locally Advanced or Metastatic Urothelial Cancer

Astellas and Seagen's Padcev (enfortumab vedotin-ejfv) Receive the US FDA's Full Approval and Expands Indication for Patients with...

July 12, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us